Retrospective Study in Patients With Metastatic Renal Cancer Treated With TKI Sequence (Tyrosine Kinase Inhibitors of VEGFR) - mTOR- Axitinib Inhibitors or Anti-VEGF Antibody -Inhibiteurs mTOR - Axitinib
Clinical trial NCT03129724 · UNKNOWN
Trial details
- NCT number
- NCT03129724
- Sponsor
- University Hospital, Strasbourg, France
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2016-09-01
- Primary completion
- 2017-07-01
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.